CD26 as a Promising Biomarker for Predicting Prognosis in Patients with Pancreatic Tumors

PURPOSE: Pancreatic cancer is associated with a high mortality rate owing to insufficient approaches for early diagnosis and the invasive biological behavior of the cancer. CD26 is a membrane-anchored protein involved in multiple physiological and pathological processes. Here, we investigated correl...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Onco Targets Ther
Päätekijät: Yan, Liang, Tian, Xiuyun, Ye, Chunxiang, Guan, Xiaoya, Dong, Bin, Zhao, Min, Wu, Jianhui, Hao, Chunyi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove 2020
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7737554/
https://ncbi.nlm.nih.gov/pubmed/33335402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S278736
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia